AstraZeneca PLC (BCBA:AZN)

AstraZeneca Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	274,068,802	209,469,693	169,189,470	37,097,138	18,693,290	11,037,557
Market Cap Growth	34.97%	23.81%	356.07%	98.45%	69.36%	39.47%
Enterprise Value	308,692,662	235,248,695	189,832,629	42,224,844	21,515,860	12,599,748
Last Close Price	44650.00	38525.84	31843.59	11111.16	5664.69	3468.18
PE Ratio	32.86	28.88	35.14	63.70	1625.31	41.07
PS Ratio	4.65	3.76	4.57	4.72	4.87	4.93
PB Ratio	6.21	4.97	5.34	5.65	4.63	8.39
P/FCF Ratio	22.90	20.45	23.29	24.03	37.36	34.20
P/OCF Ratio	19.51	17.13	20.23	21.35	30.53	27.35
EV/Sales Ratio	4.28	4.22	5.13	5.38	5.60	5.63
EV/EBITDA Ratio	12.66	12.99	16.51	17.35	31.27	21.44
EV/EBIT Ratio	17.33	17.65	24.34	27.05	72.32	34.29
EV/FCF Ratio	25.79	22.96	26.14	27.35	43.01	39.04
Debt / Equity Ratio	0.77	0.75	0.76	0.84	0.85	1.45
Debt / EBITDA Ratio	1.70	1.70	2.04	2.23	4.81	3.15
Debt / FCF Ratio	2.84	3.07	3.30	3.57	6.85	5.92
Asset Turnover	0.53	0.53	0.46	0.44	0.44	0.42
Inventory Turnover	1.72	1.80	1.59	1.26	1.85	1.45
Quick Ratio	0.69	0.67	0.58	0.62	0.67	0.67
Current Ratio	0.90	0.93	0.82	0.86	1.16	0.96
Return on Equity (ROE)	19.79%	17.59%	15.64%	8.63%	0.42%	20.80%
Return on Assets (ROA)	8.16%	7.88%	6.10%	5.46%	2.10%	4.26%
Return on Capital (ROIC)	11.73%	11.53%	8.80%	7.82%	3.26%	7.45%
Return on Capital Employed (ROCE)	17.60%	17.00%	13.70%	12.60%	3.50%	9.40%
Earnings Yield	3.04%	3.46%	2.85%	1.57%	0.06%	2.44%
FCF Yield	4.37%	4.89%	4.29%	4.16%	2.68%	2.92%
Dividend Yield	1.55%	8.30%	7.36%	4.62%	5.20%	6.79%
Payout Ratio	63.60%	65.80%	75.25%	132.72%	3442.86%	111.77%
Buyback Yield / Dilution	-0.08%	-0.06%	-0.13%	-9.32%	-8.68%	-0.92%
Total Shareholder Return	1.47%	8.23%	7.23%	-4.70%	-3.48%	5.87%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.